Showing results (281-290 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|July 3, 2013
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancerAnneke Neumann, Helen Hörzer, Nina Hillen, et al.Cancer Immunology, Immunotherapy : CII|July 10, 2013
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancerJames L Gulley, Christopher R Heery, Ravi A Madan, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Indomethacin up-regulates the generation of lymphokine-activated killer-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2A EisenthalCancer Immunology, Immunotherapy : CII|January 1, 1990
Indomethacin modulation of adriamycin-induced effects on multiple cytolytic effector functionsD L Maccubbin, S A Cohen, M J EhrkeCancer Immunology, Immunotherapy : CII|December 11, 2012
Proposed mechanism of off-target toxicity for antibody-drug conjugates driven by mannose receptor uptakeBoris Gorovits, Corinna Krinos-FiorottiCancer Immunology, Immunotherapy : CII|January 1, 1990
Age-related decrease of pulmonary metastasis of rat mammary carcinoma by activated natural resistanceN Takeichi, X B Li, J Hamada, et al.Cancer Immunology, Immunotherapy : CII|December 18, 2012
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responsesStéphanie Corgnac, Rachel Perret, Laurent Derré, et al.Cancer Immunology, Immunotherapy : CII|December 18, 2012
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responsesClaudia Durán-Aniotz, Gabriela Segal, Lorena Salazar, et al.Cancer Immunology, Immunotherapy : CII|December 26, 2012
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responsesHyun-Il Cho, Kelly Barrios, Young-Ran Lee, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2012
Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivoXiaocai Yan, Kara Doffek, Chaobo Yin, et al.Pageof 650